489 related articles for article (PubMed ID: 31789134)
1. Nanocarrier Mediated siRNA Delivery Targeting Stem Cell Differentiation.
Fernandes F; Kotharkar P; Chakravorty A; Kowshik M; Talukdar I
Curr Stem Cell Res Ther; 2020; 15(2):155-172. PubMed ID: 31789134
[TBL] [Abstract][Full Text] [Related]
2. A review of nanocarriers for the delivery of small interfering RNA.
Kesharwani P; Gajbhiye V; Jain NK
Biomaterials; 2012 Oct; 33(29):7138-50. PubMed ID: 22796160
[TBL] [Abstract][Full Text] [Related]
3. Rigid nanoparticle-based delivery of anti-cancer siRNA: challenges and opportunities.
Wang Z; Liu G; Zheng H; Chen X
Biotechnol Adv; 2014; 32(4):831-43. PubMed ID: 24013011
[TBL] [Abstract][Full Text] [Related]
4. Nanocarriers for delivery of siRNA and co-delivery of siRNA and other therapeutic agents.
Zhao J; Feng SS
Nanomedicine (Lond); 2015 Jul; 10(14):2199-228. PubMed ID: 26214357
[TBL] [Abstract][Full Text] [Related]
5. Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges.
Gomes-da-Silva LC; Fonseca NA; Moura V; Pedroso de Lima MC; Simões S; Moreira JN
Acc Chem Res; 2012 Jul; 45(7):1163-71. PubMed ID: 22568781
[TBL] [Abstract][Full Text] [Related]
6. Lipid-based Nanocarriers for siRNA Delivery: Challenges, Strategies and the Lessons Learned from the DODAX: MO Liposomal System.
Oliveira ACN; Fernandes J; Gonçalves A; Gomes AC; Oliveira MECDR
Curr Drug Targets; 2019; 20(1):29-50. PubMed ID: 29968536
[TBL] [Abstract][Full Text] [Related]
7. Stimuli-responsive hybrid nanocarriers developed by controllable integration of hyperbranched PEI with mesoporous silica nanoparticles for sustained intracellular siRNA delivery.
Prabhakar N; Zhang J; Desai D; Casals E; Gulin-Sarfraz T; Näreoja T; Westermarck J; Rosenholm JM
Int J Nanomedicine; 2016; 11():6591-6608. PubMed ID: 27994460
[TBL] [Abstract][Full Text] [Related]
8. Cell-free synthesis of connexin 43-integrated exosome-mimetic nanoparticles for siRNA delivery.
Lu M; Zhao X; Xing H; Liu H; Lang L; Yang T; Xun Z; Wang D; Ding P
Acta Biomater; 2019 Sep; 96():517-536. PubMed ID: 31284098
[TBL] [Abstract][Full Text] [Related]
9. A comprehensive update of siRNA delivery design strategies for targeted and effective gene silencing in gene therapy and other applications.
Abosalha AK; Ahmad W; Boyajian J; Islam P; Ghebretatios M; Schaly S; Thareja R; Arora K; Prakash S
Expert Opin Drug Discov; 2023 Feb; 18(2):149-161. PubMed ID: 36514963
[TBL] [Abstract][Full Text] [Related]
10. Nanoparticle-siRNA: A potential cancer therapy?
Young SW; Stenzel M; Yang JL
Crit Rev Oncol Hematol; 2016 Feb; 98():159-69. PubMed ID: 26597018
[TBL] [Abstract][Full Text] [Related]
11. Strategies for in vivo delivery of siRNAs: recent progress.
Higuchi Y; Kawakami S; Hashida M
BioDrugs; 2010 Jun; 24(3):195-205. PubMed ID: 20462284
[TBL] [Abstract][Full Text] [Related]
12. Calcium-siRNA Nanocomplexes Optimized by Bovine Serum Albumin Coating Can Achieve Convenient and Efficient siRNA Delivery for Periodontitis Therapy.
Wang Y; Song W; Cui Y; Zhang Y; Mei S; Wang Q
Int J Nanomedicine; 2020; 15():9241-9253. PubMed ID: 33262586
[TBL] [Abstract][Full Text] [Related]
13. Hydroxyapatite nanoparticles modified by branched polyethylenimine are effective non-viral vectors for siRNA transfection of hepatoma cells in vitro.
Xu XL; Yang HY; Ou B; Lin SD; Wu H; He W; Jiang QC; Luo BM; Li GP
Int J Oncol; 2015 May; 46(5):2138-42. PubMed ID: 25760143
[TBL] [Abstract][Full Text] [Related]
14. siRNA delivery using nanocarriers - an efficient tool for gene silencing.
Khurana B; Goyal AK; Budhiraja A; Arora D; Vyas SP
Curr Gene Ther; 2010 Apr; 10(2):139-55. PubMed ID: 20353386
[TBL] [Abstract][Full Text] [Related]
15. Polycation-based nanoparticle delivery for improved RNA interference therapeutics.
Howard KA; Kjems J
Expert Opin Biol Ther; 2007 Dec; 7(12):1811-22. PubMed ID: 18034647
[TBL] [Abstract][Full Text] [Related]
16. Delivering siRNA with Dendrimers: In Vivo Applications.
Leiro V; Santos SD; Pego AP
Curr Gene Ther; 2017; 17(2):105-119. PubMed ID: 28494741
[TBL] [Abstract][Full Text] [Related]
17. AIE Featured Inorganic-Organic Core@Shell Nanoparticles for High-Efficiency siRNA Delivery and Real-Time Monitoring.
He X; Yin F; Wang D; Xiong LH; Kwok RTK; Gao PF; Zhao Z; Lam JWY; Yong KT; Li Z; Tang BZ
Nano Lett; 2019 Apr; 19(4):2272-2279. PubMed ID: 30829039
[TBL] [Abstract][Full Text] [Related]
18. RNA interference-based therapy and its delivery systems.
Chen X; Mangala LS; Rodriguez-Aguayo C; Kong X; Lopez-Berestein G; Sood AK
Cancer Metastasis Rev; 2018 Mar; 37(1):107-124. PubMed ID: 29243000
[TBL] [Abstract][Full Text] [Related]
19. Targeted Delivery of siRNA Therapeutics using Ligand Mediated Biodegradable Polymeric Nanocarriers.
Cho KS; Hong SJ; Ahn MH; Pal S; Choung PH; Sangshetti J; Arote RB
Curr Pharm Des; 2018; 24(16):1788-1800. PubMed ID: 29962332
[TBL] [Abstract][Full Text] [Related]
20. Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advances.
Gandhi NS; Tekade RK; Chougule MB
J Control Release; 2014 Nov; 194():238-56. PubMed ID: 25204288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]